• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT R TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT R TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVOLUTR-26
Device Problems Device Dislodged or Dislocated (2923); Patient Device Interaction Problem (4001)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 04/11/2024
Event Type  Injury  
Event Description
Medtronic received information that during implant of this transcatheter bioprosthetic valve, the patient presented with severe aortic stenosis, bicuspid type 0 valve with severe calcification, and a pressure gradient of 108 millimeters of mercury (mmhg).A pre-implant dilation was performed with an 18 millimeter (mm) balloon.The valve was implanted under pacing rate of 180 beats per minute (bpm) at a depth of 1 mm on the non-coronary cusp (ncc) and 3 mm on the left coronary cusp (lcc).There was a plant to post dilate the valve with a 20 mm balloon, but after fully deployment of the valve, the valve gradually dislodged aortic without movement of the nose cone of the delivery catheter system (dcs).The left ventricular outflow tract (lvot) gradient was effected and a systolic blood pressure of 180 mmhg was reported.The valve was snared into the ascending aorta and a new valve was loaded.The native valve was pre-dilated again with an 18 mm balloon.The second valve was fully deployed under pacing at an implant depth of 5 mm on the ncc and 6 mm on the lcc.The valve was post dilated with a 20 mm balloon two times.The final angiogram showed trace paravalvular leak (pvl) with a gradient of 6 mmhg.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Updated data: a3b b5 continuation of d10: product id: evolutr-26; product lot/serial number (b)(6); product type: heart valve; implant date: (b)(6) 2024; product id: envpro-14; product lot/serial number (b)(6); product type: delivery catheter system; this regulatory report is associated to regulatory report 2025587-2024-02356.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information was received that the post implant balloon aortic valvuloplasty (bav) was performed due to expansion issues and the patient was rapid paced during the bav.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT R TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19123053
MDR Text Key340337218
Report Number2025587-2024-02308
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeTH
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/17/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberEVOLUTR-26
Device Catalogue NumberEVOLUTR-26
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/17/2024
Date Device Manufactured05/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexFemale
Patient Weight64 KG
-
-